A stunning stock market recovery caps a surreal year in the markets and offers me a golden opportunity to take a little risk off the table.
Unpleasant news from both these companies has me re-thinking my exposure to these speculative growth stories and selling out at a loss.
I cast a critical eye on my recent performance and uncover some interesting stats from a pile of old brokerage statements.
Looking across the valley to the other side of this crisis, I plan for an eventual recovery and add 5 new stocks to the portfolio: Teck Resources, Magellan Aerospace, Foot Locker, Adcore Inc and PHX Energy Services.
With a very aggressively positioned portfolio, I am charging full steam ahead into the new decade.
As signs of an impending recession accumulate and trade war tariffs loom, the resultant investor gloom is throwing up some very interesting investment opportunities.
After an extensive review of the investment landscape following the first quarter earnings season, I decide to jettison Preformed Line Products from the portfolio, take profits on PHX Energy Services and add a new name, Bird Construction to the stable.
In the final 2 months of the year I sold Atlas Engineered Products, pared back on my Essential Energy Services and Geodrill holdings and added Gluskin Sheff to the mix. 2018 was a year full of surprises. I take a look back at the tumultuous year just ended and look ahead at what might be in store for investors in 2019.
A couple of sells, some market commentary and a look at the portfolio from a defensive standpoint.
The company has been growing like gangbusters while it has been out of the public eye, but are insurers willing to foot the bill?
Viemed, Questor and Magna were the bright spots in what was a fairly uneventful start to the year. With the market undecided as to which direction it wants to go, I maintain my hedge but use up most of my remaining cash to add 4 new holdings to the portfolio.
The auditors and president have just resigned, sending the stock price down in flames.
Assure Holdings performs its first neuromonitoring case in Louisiana.